All Departments
Chronic Metabolic Diseases
Metabolism is defined as the sum of enzyme-mediated chemical reactions that take place within each cell of a living organism and that provide energy for vital processes and for synthesizing new organic material.
Vital processes include movement, growth and development, and reproduction.
Metabolic disorders, including neuro-metabolic disorders, are often defined as non-communicable diseases.
Metabolic Syndrome (MS), also known as syndrome X, is characterized by a group of interconnected pathophysiological conditions, such as central obesity, hyperglycemia, hyperlipidemia, atherosclerosis, increased risk of hypertension, coronary heart disease, and stroke.
Ready to Transform Your Business Growth? Start Your Journey Today!
Strategies for Explosive Business Growth: Achieving High-Impact Development
DIABESITY
Diabesity is a term used to describe the combined adverse health effects of obesity and diabetes mellitus. The worldwide dual epidemic of obesity and type 2 diabetes is an important public health issue and socio-economic burden. Projections estimate a sixfold increase in the number of adults with obesity in 40 years and an increase in the number of individuals with diabetes to 642 million by 2040. Increased adiposity is the strongest risk factor for developing diabetes.
Due to the strong association of obesity and diabetes, the term “diabesity” was coined, suggesting a causal pathophysiological link between both phenomena. However, while obesity is considered the main risk factor in the development of type 2 diabetes in some people, it does not directly cause type 2 diabetes.
Between 80 and 90% of individuals with T2DM are overweight or obese.
Some evidence indicates that an individual with obesity is approximately 10 times more likely to
develop type 2 diabetes than someone with a moderate body weight.
Obesity also causes diabetes to worsen faster.
Unlike with Type 2 diabetes, the majority of people with Type 1 diabetes aren’t obese. But, there’s an association between obesity and the onset of Type 1 diabetes. Weight gain lowers the age at which a diagnosis is made. This is called “the accelerator hypothesis” (caused by insulin resistance). It states that weight gain speeds up the onset of diabetes in people who are already genetically predisposed to the condition.


METABESITY
Zan Fleming, October 15, 2019, London, UK: in "Metabesity and Longevity: USA Special Case Study
Metabesity denotes the common metabolic roots behind some of the most prevalent and costly degenerative diseases burdening the USA economy today. Much of biological aging, which is the largest risk factor for such diseases, can be considered as a disintegration of normal metabolic functioning and coordination. This means that the most effective and economic approach to healthcare necessarily involves the prevention of costly chronic diseases by intervening upon their shared metabolic roots as early as possible, to prevent rather than to treat.
Expert Panel on Metabesity: recommendation for taking up the challenge by a multidisciplinary approach. Syed Abbas Raza 1 , Sobia Sabir Sabir 2 , Kamran Babar Ali 3 , Choudhary Asad Ali 4 , Amir Riaz 5 , Irshad Hussain 6 , Shujaat Hussain 7 , Mujeeb Ullah Tareen 8 , Khalid Imran Mubeen 9 , Riyaz Shahzad 10, Shahbaz Sarwar